Dimethylformamide → N-(4-Methoxybenzyl) 4-amino-2-methylmercaptopyrimidine-5-carboxyamide

HRID 2354615

Reaktionsgleichung

Reaktionsgleichung von HRID 2354615
[NH2:1][C:2]1[C:7]([C:8](O)=O)=[CH:6][N:5]=[C:4]([S:11][CH3:12])[N:3]=1.[CH3:13][O:14][C:15]1[CH:22]=[CH:21][C:18]([CH2:19][NH2:20])=[CH:17][CH:16]=1.ON1C2C=CC=CC=2N=N1.CN(C)[CH:35]=[O:36]>>[CH3:13][O:14][C:15]1[CH:22]=[CH:21][C:18]([CH2:19][NH:20][C:35]([CH2:8][C:7]2[C:2]([NH2:1])=[N:3][C:4]([S:11][CH3:12])=[N:5][CH:6]=2)=[O:36])=[CH:17][CH:16]=1

Komponenten

5

Versuchsvorschrift

To a solution of 4-amino-2-methylmercaptopyrimidine-5-carboxylic acid (185 mg, 1 mmol) and p-methoxybenzyl amine (164 mg, 1.2 mmol) in N,N-dimethylformamide was added 1-hydroxybenzotriazole (92 mg, 92 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarboiimide hydrochloride (229 mg, 1.2 mmol). The reaction mixture was stirred at room temperature over night. The solvent was removed under reduce pressure. The residue was dissolved in ethyl acetate (30 mL) and washed by water (30 mL) and brine (30 mL), dried over sodium sulfate, and the solvent was evaporated. The residue was purified by column chromatography (hexanes:ethyl acetate=1:1) to give the desired product as a white powder (245 mg, 81%).

Aufarbeitung

  1. customThe solvent was removed
  2. dissolutionThe residue was dissolved in ethyl acetate (30 mL)
  3. washwashed by water (30 mL) and brine (30 mL)
  4. dry with materialdried over sodium sulfate
  5. customthe solvent was evaporated
  6. customThe residue was purified by column chromatography (hexanes:ethyl acetate=1:1)

Quellen und Nachweise

ORD-Eintrag
ord-3feaa15befa4439a9c6e817c5863b524
Quelldatensatz
uspto-grants-2010_07
Patentnummer
US07754726B2

Verknüpfte Notizen

Wird geladen…